Literature DB >> 22359015

Effect of serum type and concentration on the expression ofβ-galactosidase in recombinant vaccinia virus infected HeLa S3 cells.

S C Jun1, G M Lee, S H Chang, J H Kim.   

Abstract

The effect of serum type and concentration on recombinant protein expression in vaccinia virus infected HeLa S3 cells was studied in both static and suspension culture. A model heterologous protein,β-galactosidase (β-gal), was used. Calf and horse sera in the range of 0.5-10%(v/v) were investigated. In static culture, the calf serum concentration did not show any significant influence on the β-gal production which was almost completed within 24h postinfection (pi). Higher horse serum concentration, on the other hand, resulted in higher β-gal concentration which continued to increase until 48 h pi. Total β-gal concentrations in 0.5% calf serum at 24 h pi and 10% horse serum at 48 h pi were 2.2±0.7 and 2.2±0.1 IU/ml, respectively. In suspension culture, both sera showed their respective effects on the β-gal production similar to those observed in static culture, indicating that the cultivation method had little influence on β-gal production. Accordingly, the use of 0.5% calf serum after virus infection in recommended for economical β-gal production.

Entities:  

Year:  1995        PMID: 22359015     DOI: 10.1007/BF00749770

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  19 in total

1.  Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system.

Authors:  T J Wickham; T Davis; R R Granados; M L Shuler; H A Wood
Journal:  Biotechnol Prog       Date:  1992 Sep-Oct

Review 2.  Regulation of vaccinia virus transcription.

Authors:  B Moss
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

3.  Studies on the mechanism of entry of vaccinia virus in animal cells.

Authors:  R A Janeczko; J F Rodriguez; M Esteban
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

Review 4.  Vaccinia virus: a tool for research and vaccine development.

Authors:  B Moss
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

5.  Physiological factors of growth and susceptibility to virus regulating Vero cells for optimum yield of vaccinia and cloned gene product (beta-hCG).

Authors:  A Mukhopadhyay; S N Mukhopadhyay; G P Talwar
Journal:  J Biotechnol       Date:  1994-08-15       Impact factor: 3.307

Review 6.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

Review 7.  Vaccinia virus: a versatile tool for molecular biologists.

Authors:  J N Miner; D E Hruby
Journal:  Trends Biotechnol       Date:  1990-01       Impact factor: 19.536

8.  Expression of Sindbis virus structural proteins via recombinant vaccinia virus: synthesis, processing, and incorporation into mature Sindbis virions.

Authors:  C M Rice; C A Franke; J H Strauss; D E Hruby
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

9.  High level expression of active human prothrombin in a vaccinia virus expression system.

Authors:  F G Falkner; P L Turecek; R T MacGillivray; W Bodemer; F Scheiflinger; S Kandels; A Mitterer; O Kistner; N Barrett; J Eibl
Journal:  Thromb Haemost       Date:  1992-08-03       Impact factor: 5.249

10.  Expression and cell type--specific processing of human preproenkephalin with a vaccinia recombinant.

Authors:  G Thomas; E Herbert; D E Hruby
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.